ATE272072T1 - Verfahren zur reinigung von menschlichem interleukin-1 rezeptor antagonist aus rekombinanten e.coli - Google Patents

Verfahren zur reinigung von menschlichem interleukin-1 rezeptor antagonist aus rekombinanten e.coli

Info

Publication number
ATE272072T1
ATE272072T1 AT97923960T AT97923960T ATE272072T1 AT E272072 T1 ATE272072 T1 AT E272072T1 AT 97923960 T AT97923960 T AT 97923960T AT 97923960 T AT97923960 T AT 97923960T AT E272072 T1 ATE272072 T1 AT E272072T1
Authority
AT
Austria
Prior art keywords
coli
recombinant
value
receptor antagonist
human interleukin
Prior art date
Application number
AT97923960T
Other languages
English (en)
Inventor
Dino Zanette
Edoardo Giacomo Sarubbi
Adolfo Soffientini
Original Assignee
Aventis Bulk S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Bulk S P A filed Critical Aventis Bulk S P A
Application granted granted Critical
Publication of ATE272072T1 publication Critical patent/ATE272072T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97923960T 1996-06-07 1997-05-21 Verfahren zur reinigung von menschlichem interleukin-1 rezeptor antagonist aus rekombinanten e.coli ATE272072T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96109153 1996-06-07
PCT/EP1997/002591 WO1997047650A1 (en) 1996-06-07 1997-05-21 Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli

Publications (1)

Publication Number Publication Date
ATE272072T1 true ATE272072T1 (de) 2004-08-15

Family

ID=8222862

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97923960T ATE272072T1 (de) 1996-06-07 1997-05-21 Verfahren zur reinigung von menschlichem interleukin-1 rezeptor antagonist aus rekombinanten e.coli

Country Status (11)

Country Link
EP (1) EP0938501B1 (de)
JP (1) JP2000512143A (de)
AT (1) ATE272072T1 (de)
AU (1) AU717003B2 (de)
CA (1) CA2257294C (de)
DE (1) DE69730041T2 (de)
DK (1) DK0938501T3 (de)
ES (1) ES2221688T3 (de)
IL (1) IL127155A (de)
PT (1) PT938501E (de)
WO (1) WO1997047650A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927801D0 (en) * 1999-11-24 2000-01-26 Danisco Method
WO2001041792A1 (en) * 1999-12-10 2001-06-14 Amgen, Inc. Interleukin-1 receptor antagonist-like molecules and uses thereof
US20080166762A1 (en) * 2006-09-27 2008-07-10 Reliance Life Science Pvt.Ltd. HETEROLOGOUS PRODUCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST (IL-1Ra) IN PICHIA PASTORIS
JP2010515441A (ja) * 2007-01-15 2010-05-13 アップフロント・クロマトグラフィ・アクティーゼルスカブ 原材料からのバイオ燃料およびタンパク質の製造
DE202007002869U1 (de) 2007-02-27 2008-07-10 Ds Dichtungstechnik Gmbh Dichtring und Steckmuffenverbindung
JP2014522868A (ja) * 2011-07-29 2014-09-08 イレブン・バイオセラピユーテイクス・インコーポレイテツド 精製タンパク質
EP2682168A1 (de) 2012-07-02 2014-01-08 Millipore Corporation Reinigung biologischer Moleküle
EP3844170A1 (de) 2018-08-29 2021-07-07 Merck Biodevelopment S.A.S. Neues reinigungsverfahren

Also Published As

Publication number Publication date
DE69730041D1 (de) 2004-09-02
ES2221688T3 (es) 2005-01-01
DE69730041T2 (de) 2005-07-21
DK0938501T3 (da) 2004-11-15
CA2257294A1 (en) 1997-12-18
EP0938501A1 (de) 1999-09-01
AU2958697A (en) 1998-01-07
CA2257294C (en) 2006-03-14
JP2000512143A (ja) 2000-09-19
AU717003B2 (en) 2000-03-16
PT938501E (pt) 2004-11-30
IL127155A0 (en) 1999-09-22
WO1997047650A1 (en) 1997-12-18
IL127155A (en) 2007-05-15
EP0938501B1 (de) 2004-07-28

Similar Documents

Publication Publication Date Title
US6399333B1 (en) Process for producing erythropoietin containing no animal proteins
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
EP0134385A3 (en) A protein having cell growth stimulating action, composition thereof and method for producing the same
NZ504752A (en) Hydrophobically-modified protein compositions (particularly hedgehog proteins)
CA2183888A1 (en) Antibody purification
AU698334B2 (en) Method for isolation of highly pure von willebrand factor
ES2156991T3 (es) Procedimiento de produccion de albumina de elevada pureza.
ATE242317T1 (de) Verfahren zur reinigung von viren mit chromatographie
EP1273592A3 (de) Verfahren für die Reinigung von pharmakologisch aktiven Proteinen mittels Kationen-Austauschchromatographie
AU2671795A (en) Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
IL173399A0 (en) Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy
AU656552B2 (en) Process for isolating human albumin from supernatant IV, in particular IV-4, or from COHN's fraction V or from an analogous supernatant or fraction
CA2127362A1 (en) Expression and Purification of Recombinant Soluble Tissue Factor
WO1995009872B1 (en) Dna encoding prostaglandin receptor ip
SE9603068D0 (sv) Process for purifying a protein
WO1995019570B1 (en) Antagonists to insulin receptor tyrosine kinase inhibitor
WO1995000551B1 (en) Prostaglandin receptor fp and dna encoding it
AU5996996A (en) Al/fe-treatment of a protein solution, followed by membrane concentration
ATE272072T1 (de) Verfahren zur reinigung von menschlichem interleukin-1 rezeptor antagonist aus rekombinanten e.coli
Fahnestock et al. Reconstitution of 50S ribosomal subunits from protein-free ribonucleic acid
IE801589L (en) Homogenous fibroblast interferon
MY125980A (en) Highly purified cytokine activating factor and methods of use
DE69637154D1 (de) Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins
WO1995000552B1 (en) Prostaglandin receptor ep3 and dna encoding it
AU7508694A (en) Novel tyrosine kinase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0938501

Country of ref document: EP